Frank Famiano, MD in Bennington, VT - Hospitalist

Frank Famiano, MD is a Hospitalist physician based in Bennington, Vermont. Frank Famiano is licensed to practice in Vermont (license number 042-0009000) and his current practice location is 100 Hospital Dr, Bennington, Vermont. He can be reached at his office (for appointments etc.) via phone at (802) 442-6361.

NPI number for Frank Famiano is 1326069592 and his current mailing address is 100 Hospital Dr, Bennington, Vermont. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1326069592.

Contact Information

	Frank Famiano, MD
	100 Hospital Dr, Bennington, VT 05201-5004
	(802) 442-6361
	(802) 447-5609

Physician's Profile

Full Name	Frank Famiano
Gender	Male
Speciality	Hospitalist
Location	100 Hospital Dr, Bennington, Vermont
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1326069592
Provider Enumeration Date: 07/22/2006
Last Update Date: 01/20/2011

Medical Identifiers

Medical identifiers for Frank Famiano such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1326069592	NPI	-	NPPES
0VN0978	Medicaid	VT

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208M00000X	Hospitalist	042-0009000 (Vermont)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Frank Famiano is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Frank Famiano, MD 100 Hospital Dr, Bennington, VT 05201-5004 Ph: (802) 444-6361	Frank Famiano, MD 100 Hospital Dr, Bennington, VT 05201-5004 Ph: (802) 442-6361

News Archive

Ormco Corporation and Align Technology agree to collaborate and settle patent litigation

Ormco Corporation, a subsidiary of Danaher Corporation (NYSE: DHR) today announced that Ormco and Align Technology, Inc. (Nasdaq: ALGN) have agreed to enter into an exclusive collaboration arrangement to jointly develop and market an orthodontic product offering that will provide orthodontic patients a treatment solution that involves a combination of Align's Invisalign(R) system and Ormco's Insignia(R) custom orthodontic bracket and arch wire system.

Primary sclerosing cholangitis: Therapy with synthetic bile acid acts directly on the immune system

Primary Sclerosing Cholangitis (PSC) is a rare, chronic inflammatory disease of the bile ducts and is difficult to treat. Studies conducted by the Division of Gastroenterology and Hepatology at MedUni Wien under the guidance of Michael Trauner (Department of Internal Medicine III) were able to show positive effects from the administration of synthetically produced bile acids and bile acid receptor agonists.

Study: Yoga and mindfulness may help elementary school students manage stress, anxiety

Yoga/mindfulness activities may facilitate stress management among elementary school students and may be added as a complement to social and emotional learning activities, according to a Tulane University study.

Omniflight Helicopters check airman recognized with HAI prominent award

Omniflight Helicopters, Inc., a leading national provider of air medical services, announced today that John Thomas Read, check airman and flight instructor for the company, is the recipient of the W. A. (Dub) Blessing Certified Flight Instructor of the Year Award from The Helicopter Association International (HAI).

FDA grants five-year New Chemical Entity exclusivity to VYVANSE

Shire plc, the global specialty biopharmaceutical company, announces that the Food and Drug Administration (FDA), following a thorough administrative review of governing statutory and regulatory standards and public comments, has affirmed its prior decision to grant five-year New Chemical Entity (NCE) exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).

Hospitalist Doctors in Bennington, VT

Ann Marie Swann, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Dr, Bennington, VT 05201 Phone: 802-442-6361 Fax: 802-447-5609
Elizabeth A Whateley, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Dr, Bennington, VT 05201 Phone: 802-442-6361 Fax: 802-447-5609
William R Tock, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Dr, Bennington, VT 05201 Phone: 802-442-6361 Fax: 802-447-5609

Frank Famiano, MD - Hospitalist in Bennington, VT